Product Information
FT CHILD COLD-COUGH RLF DM LIQ is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0181 per ML under NDC 70677128701. Its NADAC has been published 50 times since Oct 22, 2025.
Strength
2; 10 mg/10mL; mg/10mL
Manufacturer
Strategic Sourcing Services LLCNDC
70677128701
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/25/2025
Pharmacological Classes
Price Statistics
The NADAC for FT CHILD COLD-COUGH RLF DM LIQ has been published 50 times since Oct 22, 2025, and over the history we have for it it has declined 8.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0181 per ML |
|---|---|
| All-time high | $0.0199 (Nov 12, 2025) |
| All-time low | $0.0180 (Mar 18, 2026) |
| 52-week high | $0.0199 |
| 52-week low | $0.0180 |
| Median price | $0.0184 |
| Average price | $0.0186 |
| Largest weekly change | -3.9% (Jan 21, 2026) |
| Weeks tracked | 50 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
brompheniramine maleate, dextromethorphan hydrobromide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT CHILD COLD-COUGH RLF DM LIQ?
The current National Average Drug Acquisition Cost (NADAC) for FT CHILD COLD-COUGH RLF DM LIQ, manufactured by Strategic Sourcing Services LLC, is $0.0181 per ML (NDC 70677128701), effective Sep 30, 2026.
How has the price of FT CHILD COLD-COUGH RLF DM LIQ changed over time?
Over the history we have for it, the NADAC for FT CHILD COLD-COUGH RLF DM LIQ has declined 8.8%. It has been tracked across 50 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for FT CHILD COLD-COUGH RLF DM LIQ?
Since Oct 22, 2025, the NADAC for FT CHILD COLD-COUGH RLF DM LIQ has ranged from a low of $0.0180 (Mar 18, 2026) to a high of $0.0199 (Nov 12, 2025), with a median of $0.0184 per ML.
Are there cheaper alternatives to FT CHILD COLD-COUGH RLF DM LIQ?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT CHILD COLD-COUGH RLF DM LIQ in a comparable dosage form, but none are currently priced below it.
Who manufactures FT CHILD COLD-COUGH RLF DM LIQ?
FT CHILD COLD-COUGH RLF DM LIQ (NDC 70677128701) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.